NCT00556621View on ClinicalTrials.gov

Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Bladder Cancer
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

PROCEDURE

biopsy

PROCEDURE

cystoscopy

PROCEDURE

therapeutic conventional surgery

RADIATION

radiation therapy

Trial Locations (1)

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

All Listed Sponsors
collaborator

Groupe D'Etude des Tumeurs Uro-Genitales

OTHER

lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT00556621 - Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer | Biotech Hunter | Biotech Hunter